A precision medicine initiative may involve large amounts of data. Amazon has unveiled a new biomedical data service that will help hospitals and health systems “ingest, store, query, and analyze their health data at scale.” What does it mean?
A San Francisco-based otolaryngology practice recently implemented genetic-based treatment offerings. Lessons learned here could be used to guide other practice or hospital leaders that are developing a precision medicine strategy.
James Glazier, PhD, is a professor of intelligent systems at the Indiana Luddy School of Informatics, Computing, and Engineering. Dr. Glazier is uncovering new potential in the concept of “digital twins.” His findings were published in Science. What are digital twins and why are they becoming important for precision medicine?
German-based diagnostics company identifies biomarkers that could help reduce sepsis costs, suggests basing a precision medicine initiative in the hospital ICU.
Personalized Medicine Discovery May Improve Hospitals’ Sepsis Outcomes Read More »
New precision medicine breakthrough will enable 3D printing of medications that are personalized to a specific patient’s needs. Early adopters of precision medicine may find value in this new strategy that is focused on medication management.
A new program explores the possibility of treating Alzheimer’s disease using precision medicine. What is Accelerating Medicines Partnership Alzheimer’s disease program (AMP AD 2.0), and where is research advancing?
NIH Launches New Program to Enable Precision Medicine Treatments for Alzheimer’s Disease Read More »
Insights into a recently published comprehensive review in Cancer Reports. The review, featuring Icahn School of Medicine at Mount Sinai researchers, discusses the implications of using precision medicine to treat prostate cancer in different populations, particularly African American men.
This research provides new findings on how the scope of genetic testing programs should be expanded, answers what is Watershed.
Oportunities for precision medicine partnerships. With COVID-19, precision medicine focuses on better understanding of how and why the coronavirus affects different individuals in different ways. This in turn indicates types of treatments that can be targeted toward biological pathways that vary between individuals.
Precision Medicine Research Providing Potential for COVID-19 Breakthroughs Read More »
Recent research into the human chronobiome has shown that the “normal” circadian rhythm can vary significantly in healthy individuals. This means that chronotherapies which are based on an average individual’s circadian rhythm may not be as efficacious for everyone.
